| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8595628 | Journal of Stroke and Cerebrovascular Diseases | 2018 | 10 Pages |
Abstract
Low-dose tPA is comparable to standard-dose tPA in improving the neurologic function and reducing mortality in AIS patients. Moreover, low-dose tPA can reduce the incidence of SICH compared with standard-dose tPA. Therefore, low-dose tPA is highly recommended in AIS patients.
Related Topics
Health Sciences
Medicine and Dentistry
Clinical Neurology
Authors
Ji-Wei MD, Xiao-Jing MD, Li-Shan MD, Guo-Yi MD, Li-Jun MD, Kang-Xiang MD, Qing MD, Yu MD,